Literature DB >> 25159247

Early coagulopathy at hospital admission predicts initial or delayed fibrinogen deficit in severe trauma patients.

Pauline Deras1, Maxime Villiet, Jonathan Manzanera, Pascal Latry, Jean-François Schved, Xavier Capdevila, Jonathan Charbit.   

Abstract

BACKGROUND: Early detection of a fibrinogen deficit in the initial phase of trauma is a determinant for anticipating massive blood loss. Hemostatic impairment should rationally be associated with an overall depletion of clotting factors, leading to early coagulopathy. The main objective of this study was to evaluate whether the severity of coagulopathy at admission could predict an initial and delayed fibrinogen deficit during the initial management of severe trauma patients.
METHODS: All severe trauma patients admitted consecutively to our trauma center between January 2006 and December 2009 were retrospectively reviewed. The results of coagulation tests and plasma fibrinogen levels at admission were studied. Patients were grouped according to severity of coagulopathy at admission: prothrombin time ratio and/or activated partial thromboplastin time ratio of 1.50 or greater, between 1.49 and 1.20, or less than 1.20. Correlation between severity of coagulopathy at admission and initial or delayed fibrinogen deficit (fibrinogen level < 1.5 g/L) within the first 24 hours was established.
RESULTS: Of the 663 patients studied, 481 (72%) were male, and the mean (SD) Injury Severity Score (ISS) was 21.3 (17.6). At admission, 105 patients (20%) had severe coagulopathy, 215 (33%) had moderate coagulopathy, and 313 (47%) had no coagulopathy. The number of patients with a fibrinogen level less than 1.5 g/L at admission increased with the severity of coagulopathy: 87%, 29%, and 1%, respectively (p < 0.001). Corresponding rates for an initial fibrinogen level less than 1.0 g/L were 53%, 2%, 0.3%, respectively (p < 0.001). Moreover, severity of coagulopathy at admission was an independent risk factor of the occurrence of fibrinogen deficit within the first 24 hours (p < 0.001).
CONCLUSION: Early coagulopathy at admission in severe trauma patients was strongly associated with a fibrinogen deficit during initial management. In the absence of specific monitoring of fibrinogen, coagulopathy severity helps to guide fibrinogen replacement therapy. LEVEL OF EVIDENCE: Prognostic and epidemiologic study, level III.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25159247     DOI: 10.1097/TA.0000000000000314

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  6 in total

1.  The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition.

Authors:  Donat R Spahn; Bertil Bouillon; Vladimir Cerny; Jacques Duranteau; Daniela Filipescu; Beverley J Hunt; Radko Komadina; Marc Maegele; Giuseppe Nardi; Louis Riddez; Charles-Marc Samama; Jean-Louis Vincent; Rolf Rossaint
Journal:  Crit Care       Date:  2019-03-27       Impact factor: 9.097

2.  Viscoelastic measurements of platelet function, not fibrinogen function, predicts sensitivity to tissue-type plasminogen activator in trauma patients.

Authors:  H B Moore; E E Moore; M P Chapman; E Gonzalez; A L Slaughter; A P Morton; A D'Alessandro; K C Hansen; A Sauaia; A Banerjee; C C Silliman
Journal:  J Thromb Haemost       Date:  2015-09-22       Impact factor: 5.824

3.  The authors reply.

Authors:  Ithan D Peltan; Timothy R Watkins
Journal:  Crit Care Med       Date:  2016-02       Impact factor: 7.598

Review 4.  Resuscitative Strategies to Modulate the Endotheliopathy of Trauma: From Cell to Patient.

Authors:  Feng Wu; Amanda Chipman; Shibani Pati; Byron Miyasawa; Laurence Corash; Rosemary A Kozar
Journal:  Shock       Date:  2020-05       Impact factor: 3.533

5.  Association of an In-House Blood Bank with Therapy and Outcome in Severely Injured Patients: An Analysis of 18,573 Patients from the TraumaRegister DGU®.

Authors:  Florian Debus; Rolf Lefering; Philipp Lechler; Tim Schwarting; Benjamin Bockmann; Erwin Strasser; Carsten Mand; Steffen Ruchholtz; Michael Frink
Journal:  PLoS One       Date:  2016-11-03       Impact factor: 3.240

Review 6.  Massive hemorrhage management-a best evidence topic report.

Authors:  Tomas Vymazal
Journal:  Ther Clin Risk Manag       Date:  2015-07-27       Impact factor: 2.423

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.